Cite Filings / FATE / 0001104659-24-131793

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

FATE THERAPEUTICS INC Filed 2024-12-26 Acc 0001104659-24-131793

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-07-03 SCHEDULE 13D/A Beneficial Ownership Report
2024-12-26 4 Director bought 397,964 shares at $1.68 ($668,580)
2024-12-26 SCHEDULE 13D/A Beneficial Ownership Report
2024-12-20 144 Sale of Securities

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…